Low Dose Naltrexone for the
Treatment
of Fibromyalgia
Screening
Your responses to this screening questionnaire are confidential and are held on secure medical servers at Stanford University. The system is fully HIPAA compliant. The screening questionnaire should take about 15-20 minutes to complete. Once we have had a chance to review your responses, we will contact you regarding further participation. Note that you are not obligated to participate. Alternatively, you can call us from 9am – 5pm Monday through Friday at: 650-724-0522. Mention the low-dose naltrexone study.
This study is being funded by the non-profit organization: the American Fibromyalgia Syndrome Association (AFSA). There are no pharmaceutical industry or business interests involved in this study.
COMPLETE THE SCREENING QUESTIONNAIRE
